Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?


OverviewForecastFinancialsChart

Outlook Therapeutics Ownership Summary


Outlook Therapeutics is owned by 4.35% institutional investors, 36.39% insiders, and 59.25% retail investors. Vanguard group is the largest institutional shareholder, holding 3.63% of OTLK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.20% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOutlook Therapeutics4.35%36.39%59.25%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.34M3.63%$1.42M
Schonfeld strategic advisors715.17K1.94%$758.08K
Blackrock funding, inc. /de369.73K1.00%$391.92K
Geode capital management306.30K0.83%$324.75K
Commonwealth equity services113.15K0.31%$120.00K
Simplex trading89.24K0.24%$94.00K
State street75.30K0.20%$79.82K
Scotia capital73.99K0.20%$78.43K
Lvw advisors48.23K0.13%$51.13K
Ubs group48.11K0.13%$51.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Christensen, king & associates investment services27.21K0.01%$28.84K
Flower city capital20.00K0.01%$21.20K
Two sigma securities35.66K0.01%$37.80K
Lvw advisors48.23K0.01%$51.13K
Schonfeld strategic advisors715.17K0.00%$758.08K
Point72 asia (singapore) pte.5.82K0.00%$6.16K
Xtx topco11.01K0.00%$11.67K
Scotia capital73.99K0.00%$78.43K
Oppenheimer13.00K0.00%$13.78M
Vanguard personalized indexing management13.89K0.00%$14.73K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.34M-91.03K
Simplex trading89.24K-89.24K
Commonwealth equity services113.15K0.00%85.00K
Geode capital management306.30K-40.66K
Two sigma securities35.66K0.01%35.66K

Top Sellers

HolderShares% AssetsChange
Sphera funds management---857.14K
Schonfeld strategic advisors715.17K0.00%-649.64K
Rosalind advisors---450.00K
Morgan stanley775.00--424.82K
Tang capital management---400.00K

New Positions

HolderShares% AssetsChangeValue
Simplex trading89.24K-89.24K$94.00K
Two sigma securities35.66K0.01%35.66K$37.80K
Flower city capital20.00K0.01%20.00K$21.20K
Jones financial companies lllp2.50K-2.50K$2.42K
Wealthspire advisors300.00-300.00$318.00

Sold Out

HolderChange
Ifp advisors-3.00
True wealth design-20.00
Corecap advisors-62.00
Sterling capital management-116.00
Point72 (difc)-383.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202516-73.77%1,609,381-69.77%41.46%8-75.00%4-75.00%
Jun 30, 2025641.59%5,935,574-16.22%193.65%33-13.16%1838.46%
Mar 31, 2025633.28%7,084,42564.93%227.30%388.57%138.33%
Dec 31, 202461-12.86%4,295,401-48.73%170.87%35-12.50%1220.00%
Sep 30, 20241-450,000-119.48%--100.00%--

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv942.80K2.20%-20.61K
Vanguard US Total Market Shares ETF442.51K1.38%-
Vanguard Institutional Extnd Mkt Idx Tr245.51K0.57%-35.77K
CREF Stock R1100.34K0.42%65.13K
Fidelity Small Cap Index169.90K0.40%-6.23K
Federated Hermes MDT Small Cap Growth IS88.30K0.37%88.30K
Federated Hermes MDT SCG Institutional88.30K0.37%88.30K
Fidelity Extended Market Index125.61K0.28%-218.00
iShares Russell 2000 Growth ETF100.13K0.23%-
State St Russell Sm/Mid Cp® Indx NL Cl C66.90K0.21%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2024KENYON LAWRENCE A Chief Financial OfficerBuy$28.45K
Apr 15, 2024Syntone Ventures LLC-Buy$8.25M
Apr 15, 2024Syntone Ventures LLC-Buy$5.00M
Mar 28, 2024Haddadin Yezan Munther-Buy$22.24K
Mar 07, 2024Evanson Jeff CHIEF COMMERCIAL OFFICERBuy$26.24K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

OTLK Ownership FAQ


Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 4.35%, followed by 36.39% insiders and 59.26% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 45.22%, which Outlook Therapeutics falls below.

Who owns the most shares of Outlook Therapeutics?

Outlook Therapeutics’s largest shareholders are Vanguard group (1.34M shares, 3.63%), Schonfeld strategic advisors (715.17K shares, 1.94%), and Blackrock funding, inc. /de (369.73K shares, 1.00%). Together, they hold 6.57% of Outlook Therapeutics’s total shares outstanding.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Christensen, king & associates investment services is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 27.21K Outlook Therapeutics shares, valued at 28.84K$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Outlook Therapeutics shares, with 2.20% of its total shares outstanding invested in 942.8K Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools